JP2024534499A5 - - Google Patents
Info
- Publication number
- JP2024534499A5 JP2024534499A5 JP2024517427A JP2024517427A JP2024534499A5 JP 2024534499 A5 JP2024534499 A5 JP 2024534499A5 JP 2024517427 A JP2024517427 A JP 2024517427A JP 2024517427 A JP2024517427 A JP 2024517427A JP 2024534499 A5 JP2024534499 A5 JP 2024534499A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- acid sequence
- recombinant polypeptide
- polypeptide according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163247239P | 2021-09-22 | 2021-09-22 | |
| US63/247,239 | 2021-09-22 | ||
| PCT/US2022/076862 WO2023049803A1 (en) | 2021-09-22 | 2022-09-22 | Il5ra cell surface markers |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024534499A JP2024534499A (ja) | 2024-09-20 |
| JP2024534499A5 true JP2024534499A5 (enExample) | 2025-09-30 |
Family
ID=85721256
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024517427A Pending JP2024534499A (ja) | 2021-09-22 | 2022-09-22 | Ｉｌ５ｒａ細胞表面マーカー |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20240417443A1 (enExample) |
| EP (1) | EP4405383A4 (enExample) |
| JP (1) | JP2024534499A (enExample) |
| KR (1) | KR20240069766A (enExample) |
| CN (2) | CN118251407A (enExample) |
| AU (1) | AU2022349077A1 (enExample) |
| CA (1) | CA3232203A1 (enExample) |
| MX (1) | MX2024003250A (enExample) |
| WO (1) | WO2023049803A1 (enExample) |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5453491A (en) * | 1990-09-11 | 1995-09-26 | Kiyoshi Takatsu | Murine interleukin-5 receptor |
| EP1283878B1 (en) * | 2000-05-22 | 2005-07-27 | Vlaams Interuniversitair Instituut voor Biotechnologie vzw. | Receptor-based interaction trap |
| MX376656B (es) * | 2007-05-14 | 2025-03-07 | Kyowa Kirin Co Ltd | Metodos para reducir niveles de basófilos. |
| KR20180037275A (ko) * | 2015-08-24 | 2018-04-11 | 글락소스미스클라인 인털렉츄얼 프로퍼티 (넘버 2) 리미티드 | 생물제약 조성물 |
| EP3371225A2 (en) * | 2015-11-04 | 2018-09-12 | AstraZeneca AB | Dipeptidyl peptidase-4 and periostin as predictors of clinical response to eosinophil-targeted therapeutic agents in eosinophilic diseases |
| CA3065930A1 (en) * | 2017-06-07 | 2018-12-13 | Intrexon Corporation | Expression of novel cell tags |
| JP2023517063A (ja) * | 2020-03-10 | 2023-04-21 | マサチューセッツ インスティテュート オブ テクノロジー | 操作されたメモリー様ｎｋ細胞を作製するための方法およびその組成物 |
-
2022
- 2022-09-22 CN CN202280074739.XA patent/CN118251407A/zh active Pending
- 2022-09-22 MX MX2024003250A patent/MX2024003250A/es unknown
- 2022-09-22 CN CN202411599318.6A patent/CN119661725A/zh active Pending
- 2022-09-22 EP EP22873860.5A patent/EP4405383A4/en active Pending
- 2022-09-22 CA CA3232203A patent/CA3232203A1/en active Pending
- 2022-09-22 JP JP2024517427A patent/JP2024534499A/ja active Pending
- 2022-09-22 US US18/693,418 patent/US20240417443A1/en active Pending
- 2022-09-22 WO PCT/US2022/076862 patent/WO2023049803A1/en not_active Ceased
- 2022-09-22 KR KR1020247012657A patent/KR20240069766A/ko active Pending
- 2022-09-22 AU AU2022349077A patent/AU2022349077A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN110818802B (zh) | 一种嵌合t细胞受体star及其应用 | |
| JP2865300B2 (ja) | ヒトｂ細胞刺激因子２レセプター蛋白質 | |
| JP2021191265A5 (enExample) | ||
| JP2023071729A5 (enExample) | ||
| JP2023524054A5 (enExample) | ||
| JP2010516758A5 (enExample) | ||
| JP2021525534A5 (enExample) | ||
| HU230364B1 (hu) | Simian adenovírus nukleinsav és aminosav-szekvencia, azt tartalmazó vektorok, és eljárások annak alkalmazására | |
| CN111892661B (zh) | 一种嵌合抗原受体及其在制备治疗肿瘤的产品中的应用 | |
| CN115698081A (zh) | 靶向bcma的嵌合抗原受体及其用途 | |
| EP4021932B1 (en) | Tcr constructs specific for ebv-derived antigens | |
| CN108728460A (zh) | 靶向gd2的嵌合抗原受体及其用途 | |
| JP2024502235A5 (enExample) | ||
| EP3898665B1 (en) | Cd22-specific t cell receptors and adoptive t cell therapy for treatment of b cell malignancies | |
| CN111875708A (zh) | 一种嵌合抗原受体t淋巴细胞及其在制备治疗实体肿瘤的产品中的应用 | |
| CN107475275A (zh) | 嵌合抗原受体及其表达基因、双抗原调节的嵌合抗原受体修饰的t细胞及其应用 | |
| WO2020253879A1 (zh) | 一种双特异性嵌合抗原受体 | |
| WO1997024446A2 (en) | Gene delivery vehicle-targeting ligands | |
| CN115947824A (zh) | 突变的人源t细胞受体恒定区、t细胞受体及t细胞受体修饰的细胞及应用 | |
| JP2024534499A5 (enExample) | ||
| US11980671B2 (en) | Use of bacterial voltage gated ion channels for human therapies | |
| CN108484778B (zh) | 人源化ghr106单克隆抗体的嵌合抗原受体构建体及核酸分子与应用 | |
| JP6018079B2 (ja) | 非天然ｍｉｃタンパク質 | |
| JP2024516610A5 (enExample) | ||
| CA2660178C (en) | Promiscuous her-2/neu cd4 t cell epitopes |